Nonsuicidal Self-Injury
Conditions
Brief summary
The primary aim is to investigate the effectiveness of Emotion Regulation Individual Therapy for Adolescents (ERITA) who self-harm.
Interventions
BEHAVIORALEmotion Regulation Individual Therapy for Adolescents
Sponsors
Karolinska Institutet
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* a primary diagnosis of NSSI as defined by DSM-5 Section 3 * \< 1 NSSI episode during the past month * at least one parent needs to commit to participate in the parent program
Exclusion criteria
* bipolar disorder I or primary psychosis * severe suicidal ideation * ongoing substance dependence * Insertion/withdrawal of psychopharmacological substances within two months prior to the treatment * other acute primary axis I diagnosis (e.g. anorexia nervosa) that demand treatment in first hand * current life circumstances that would hinder the treatment (i.e. ongoing domestic abuse) * insufficient Swedish language skills * Cocurrent treatment with Mentalization based therapy (MBT) or Dialectical behavioral therapy (DBT)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Deliberate Self-Harm Inventory - 9 item version | Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in self-harming behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difficulties in Emotion Regulation Scale -16 item version (DERS-16) | Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks and at 6 months after treatment has ended. |
| Diary questionnaire (DQ) | Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in difficulties in emotion regulation when measures weekly, after 12 weeks and at 6 months after treatment has ended. |
| Difficulties in Emotion Regulation Scale (DERS) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in difficulties in emotion regulation after 12 weeks and at 6 months after treatment has ended. |
| Strengths and Difficulties Questionnaire Child and Parent version (SDQ-C/P) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in strengths and difficulties after 12 weeks and at 6 months after treatment has ended. |
| Borderline personality features in childhood (BPFS-C) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in borderline personality features after 12 weeks and at 6 months after treatment has ended. |
| The alcohol use disorders identification test - C (AUDIT-C) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in alcohol use after 12 weeks and at 6 months after treatment has ended. |
| Evaluation of the Drug Use Disorders Identification Test - C (DUDIT-C) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in drug use after 12 weeks and at 6 months after treatment has ended. |
| Borderline Symptom List Behavior supplement (BSL-supplement) | Baseline (7 days prior to treatment start), weekly (once a week following treatment start), post-treatment (12 weeks) and six months follow-up | Change from baseline in self-destructive and risky behaviors when measures weekly, after 12 weeks and at 6 months after treatment has ended. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Patient Health Questionnaire (PHQ9) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change in patient parent health from baseline after 12 weeks and at 6 months after treatment has ended. |
| General Anxiety Disorder (GAD7) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change in patient parent health from baseline after 12 weeks and at 6 months after treatment has ended. |
| The treatment credibility scale | One week after treatment start | Perceived treatment credibility |
| Working Alliance Inventory (WAI) short version | Three weeks after treatment start | Perceived working alliance |
| Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness - Child version (TiC-P) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change from Baseline in societal costs after 14 weeks and at 6- and 12 months after treatment has Change from baseline in quality of life after 12 weeks and at 6 months after treatment has ended. Used for health economic evaluations. |
| Euroqol-5D (EQ-5D) | Baseline (7 days prior to treatment start), post-treatment (12 weeks) and six months follow-up | Change from Baseline in quality of life after 14 weeks and at 6- and 12 months after treatment has Change from baseline in quality of life after 12 weeks and at 6 months after treatment has ended. Used for health economic evaluations. |
Countries
Sweden
Outcome results
None listed